Latest news
Advanced Renal Cell Carcinoma: Interpreting Emerging Evidence for Belzutifan-Based Therapies - Targeted OncologyTargeted Oncology · Thu, 06 Aug 2026 12:05:08 GMTBaseline and On-Treatment QOL Improvements Track With Survival Benefits With Belzutifan or Everolimus in ccRCC - OncLiveOncLive · Fri, 31 Jul 2026 12:04:51 GMTBelzutifan Combo Exhibits Comparable HRQoL Vs Cabozantinib in RCC - CancerNetworkCancerNetwork · Mon, 27 Jul 2026 15:08:04 GMT